Amicus Therapeutics (FOLD) Q4 Earnings and Revenues Miss Estimates
Portfolio Pulse from
Amicus Therapeutics (FOLD) reported Q4 earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.10 per share. This is an improvement from a loss of $0.11 per share a year ago.
February 19, 2025 | 2:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amicus Therapeutics reported Q4 earnings of $0.09 per share, missing the consensus estimate of $0.10. Despite the miss, this is an improvement from a $0.11 loss per share a year ago.
The earnings miss is likely to have a negative short-term impact on the stock price as it failed to meet analyst expectations. However, the improvement from last year's loss may mitigate some negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100